Optimized zein nanospheres for improved oral bioavailability of atorvastatin

References

• CorsiniAMaggiFMCatapanoALPharmacology of competitive inhibitors of HMG-CoA reductasePharmacol Res1995319277784310
   PubMed Web of Science ®Google Scholar
• IgelMSudhopTvonBKPharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatinJ Clin Pharmacol20024283584512162466
   PubMed Web of Science ®Google Scholar
• BreitkreitzMCSabinGPPollaGPoppiRJCharacterization of semisolid self-emulsifying drug delivery systems (SEDDS) of atorvastatin calcium by Raman image spectroscopy and chemometricsJ Pharm Biomed Anal20137331222522036
   PubMed Web of Science ®Google Scholar
• SheteGPuriVKumarLBansalAKSolid state characterization of commercial crystalline and amorphous atorvastatin calcium samplesAAPS Pharm Sci Tech201011598609
   PubMed Web of Science ®Google Scholar
• RonaldsonKJO’SheaJMBoydIWRisk factors for rhabdomyolysis with simvastatin and atorvastatinDrug Saf2006291061106717061911
   PubMedGoogle Scholar
• ZhongQJinMNanoscalar structures of spray-dried zein microcapsules and in vitro release kinetics of the encapsulated lysozyme as affected by formulationsJ Agric Food Chem2009573886389419415929
   PubMed Web of Science ®Google Scholar
• AhmedOAHosnyKMAl-SawahliMMFahmyUAOptimization of caseinate coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristicsDrug Des Devel Ther20159655662
   PubMed Web of Science ®Google Scholar
• ShuklaRCheryanMZein: the industrial protein from cornInd Crops Prod200113171192
   Web of Science ®Google Scholar
• MeenaAKRatnamDVChandraiahGAnkolaDDRaoPRKumarMNOral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemiaLipids20084323124118196308
   PubMed Web of Science ®Google Scholar
• DesaiDPDateAAPatravaleVBOvercoming poor oral bioavailability using nanoparticle formulations – opportunities and limitationsDrug Discov Today Technol201298795
   Google Scholar
• LiuXSunQWangHZhangLWangJYMicrospheres of corn protein, zein, for an ivermectin drug delivery systemBiomaterials20052610911515193886
   PubMed Web of Science ®Google Scholar
• LaiLFGuoHXPreparation of new 5-fluorouracil-loaded zein nano-particles for liver targetingInt J Pharm201140431732321094232
   PubMed Web of Science ®Google Scholar
• LaiLFGuoHXPreparation of new 5-fluorouracil-loaded zein nano-particles for liver targetingInt J Pharm201140431732321094232
   PubMed Web of Science ®Google Scholar
• LeeJHParkTGLeeYBShinSCChoiHKEffect of adding nonvolatile oil as a core material for the floating microspheres prepared by emulsion solvent diffusion methodJ Microencapsul200118657511201342
   PubMed Web of Science ®Google Scholar
• ChenLHebrardGBeyssacEDenisSSubiradeMIn vitro study of the release properties of soy-zein protein microspheres with a dynamic artificial digestive systemJ Agric Food Chem2010589861986720715822
   PubMedGoogle Scholar
• PodarallaSPerumalOPreparation of zein nanoparticles by pH controlled nanoprecipitationJ Biomed Nanotechnol2010631231721323103
   PubMed Web of Science ®Google Scholar
• SuzukiTSatoEMatsudaYTadaHUnnoKKatoTPreparation of zein microspheres conjugated with antitumor drugs available for selective cancer chemotherapy and development of a simple colorimetric determination of drugs in microspheresChem Pharm Bull (Tokyo)198937105110542766407
   PubMed Web of Science ®Google Scholar
• ZhangHXWangJXZhangZBLeYShenZGChenJFMicronization of atorvastatin calcium by antisolvent precipitation processInt J Pharm200937410611319446766
   PubMed Web of Science ®Google Scholar
• SahHToddywalaRChienYWThe influence of biodegradable micro-capsule formulations on the controlled release of a proteinJ Control Release199430201211
   Web of Science ®Google Scholar
• StaniszBKaniaLValidation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phaseActa Pol Pharm20064476471
   Google Scholar
• O’HaganDTJefferyHDavisSSThe preparation and characterization of PLGA microspheres: III. Microparticle/polymer degradation rates and the in vitro release of a model proteinInt J Pharm19941033745
   Web of Science ®Google Scholar
• YeoYParkKControl of encapsulation efficiency and initial burst in polymeric microparticle systemsArch Pharm Res20042711214969330
   PubMed Web of Science ®Google Scholar
• ShumYYHuangNWalterGDevelopment, validation, and interlaboratory comparison of an HMG-CoA reductase inhibition assay for quantitation of atorvastatin in plasma matricesTher Drug Monit19982041499485553
   PubMedGoogle Scholar
• ZhangYNiuYLuoYFabrication, characterization and antimicrobial activities of thymol-loaded zein nanoparticles stabilized by sodium caseinate-chitosan hydrochloride double layersFood Chem201414226927524001841
   PubMed Web of Science ®Google Scholar
• LiuYHuangLLiuFPaclitaxel nanocrystals for overcoming multi-drug resistance in cancerMol Pharm2010786386920420443
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov2010961562720616808
   PubMed Web of Science ®Google Scholar
• KumarVHongSYMaciagAEStabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and double JS-K, through incorporation into PEG-protected nanoparticlesMol Pharm2010729129820000791
   PubMed Web of Science ®Google Scholar
• LiversidgeGGCundyKCParticle-size reduction for improvement of oral bioavailability of hydrophobic drugs:1. Absolute oral bio-availability of nanocrystalline danazol in beagle dogsInt J Pharm19951259197
   Web of Science ®Google Scholar
• AhujaBKJenaSKPaidiSKBagriSSureshSFormulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspensionInt J Pharm201447854055225490182
   PubMedGoogle Scholar
• MishraBAryaNTiwariSInvestigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial designDaru2010181822615586
   PubMed Web of Science ®Google Scholar
• DasSSureshPKNanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin BNanomedicine2011224224720692375
   PubMedGoogle Scholar
• DuSZhuLDuBPharmacokinetic evaluation and antitumor activity of 2-methoxyestradiol nanosuspensionDrug Dev Ind Pharm20123843143821951208
   PubMed Web of Science ®Google Scholar
• Hurtado-LopezPMurdanSZein microspheres as drug/antigen carriers: a study of their degradation and erosion, in the presence and absence of enzymesJ Microencapsul20062330331416801242
   PubMed Web of Science ®Google Scholar